title: Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
authors.forename: G W
authors.initials: GW
authors.lastname: Coombs
authors.forename: I D
authors.initials: ID
authors.lastname: Kay
authors.forename: R A
authors.initials: RA
authors.lastname: Steven
authors.forename: J W
authors.initials: JW
authors.lastname: Pearman
authors.forename: D
authors.initials: D
authors.lastname: Bertolatti
authors.forename: W B
authors.initials: WB
authors.lastname: Grubb
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D019729:Carbon-Oxygen Ligases / Q000235:genetics; D003428:Cross Infection / Q000382:microbiology* / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects* / Q000235:genetics* / Q000302:isolation & purification; D005798:Genes, Bacterial; D005838:Genotype; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology* / Q000517:prevention & control; D006801:Humans; D010641:Phenotype; D016133:Polymerase Chain Reaction; D014640:Vancomycin / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; C071437:VanA ligase, Bacteria; C079914:VanC protein, Bacteria; D014640:Vancomycin; D019729:Carbon-Oxygen Ligases